Science & Enterprise subscription

Follow us on Twitter

  • In one of its first actions, the Biden administration rejoined the United States in the World Health Organization,… https://t.co/gpHTTr70DP
    about 12 hours ago
  • New post on Science and Enterprise: U.S. Rejoins WHO, Participates in Int’l Vaccine Project https://t.co/bBUZr5UzSg #Science #Business
    about 12 hours ago
  • A clinical trial shows long-term care residents and staff receiving a synthetic antibody treatment have a lower ris… https://t.co/EPYrP8wElE
    about 16 hours ago
  • New post on Science and Enterprise: Antibodies Prevent Covid-19 Symptoms in Long-Term Care https://t.co/sePqojZMVd #Science #Business
    about 16 hours ago
  • Another way to connect 100 million people end-to-end with Covid-19 vaccines. https://t.co/wIWk0XNDhv
    about 1 day ago

Please share Science & Enterprise

2020 Venture Funds Mixed, Biotech Keeps Sizzling

2020 venture transactions

Total venture investments in dollars jumped to a new high in the U.S., while biotechnology remained the single hottest sector in 2020. . . . → Read More: 2020 Venture Funds Mixed, Biotech Keeps Sizzling

Drug Price Disruptor Biotech Raises $500M in New Funds

Pills and dollar bill

A start-up biotechnology company that aims to bring drugs to market at lower cost is raising $500 million in its second venture funding round. . . . → Read More: Drug Price Disruptor Biotech Raises $500M in New Funds

Synthetic Biology Company Raises $105M in New Funds

DNA chip graphic

A company developing cellular and genetic therapies for cancer designed like electronic circuits is raising $105 million in its second venture round. . . . → Read More: Synthetic Biology Company Raises $105M in New Funds

Synthetic Virus Company Forms, Raises $77M

Adenovirus schematic

A new biotechnology enterprise is underway that develops synthetic viruses attacking solid tumor cancers, based on research at the Salk Institute. . . . → Read More: Synthetic Virus Company Forms, Raises $77M

Start-Up Creating Digital Therapies for Alzheimer’s

Brain cell networks

A new enterprise is developing personalized digital therapeutics for people with Alzheimer’s disease and other neurodegenerative disorders. . . . → Read More: Start-Up Creating Digital Therapies for Alzheimer’s

Biotech Creating More Efficient Crispr Therapies

DNA puzzle

A biotechnology company is developing treatments for cancer and other diseases using Crispr gene editing delivered with more efficient synthetic proteins. . . . → Read More: Biotech Creating More Efficient Crispr Therapies

Lightweight AI Chip Designer Raises $2.8M in Seed Funds

Bumble bee and flower

A new company is designing computer chips and devices with artificial intelligence modeled on insect brains for autonomous vehicles and robotic systems. . . . → Read More: Lightweight AI Chip Designer Raises $2.8M in Seed Funds

Natural-Killer Cell Cancer Therapy Biotech Launches

Natural killer cell

A new company is underway creating off-the-shelf engineered cells from the immune system as cancer treatments, and raising $42 million in venture funds. . . . → Read More: Natural-Killer Cell Cancer Therapy Biotech Launches

Biotech Manufacturing, Distribution Company Underway

Vaccine vials

A new enterprise providing manufacturing and supply chain services for biotechnology labs, including gene and RNA therapy developers, began operations. . . . → Read More: Biotech Manufacturing, Distribution Company Underway

Cancer Immune System Therapy Start-Up Raises $53M

T-cells illustration

A company developing treatments that retune the immune system to kill solid tumor and blood-related cancers is raising $53 million in its first venture funding. . . . → Read More: Cancer Immune System Therapy Start-Up Raises $53M